{"id":"ribavirin-with-adaptation-dose","safety":{"commonSideEffects":[{"rate":"20-50%","effect":"Anemia"},{"rate":"10-30%","effect":"Neutropenia"},{"rate":"5-20%","effect":"Thrombocytopenia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It does this by binding to the viral RNA polymerase, preventing the replication of the virus. This leads to a decrease in viral load and an improvement in symptoms.","oneSentence":"Ribavirin is an antiviral medication that works by inhibiting viral RNA synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:32:06.323Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic hepatitis C"},{"name":"Respiratory syncytial virus infection"}]},"trialDetails":[{"nctId":"NCT03537196","phase":"PHASE4","title":"DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C)","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2018-11-13","conditions":"Hepatitis C, Drug Use, Viral Hepatitis C","enrollment":979},{"nctId":"NCT00485342","phase":"PHASE3","title":"RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2006-04","conditions":"Chronic Hepatitis C","enrollment":236},{"nctId":"NCT00944684","phase":"PHASE2","title":"High Dose Ribavirin in the Treatment of Chronic Hepatitis C","status":"COMPLETED","sponsor":"University of Bern","startDate":"2007-11","conditions":"Chronic Hepatitis C","enrollment":32}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"ribavirin with adaptation dose","genericName":"ribavirin with adaptation dose","companyName":"Hospices Civils de Lyon","companyId":"hospices-civils-de-lyon","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ribavirin is an antiviral medication that works by inhibiting viral RNA synthesis. Used for Chronic hepatitis C, Respiratory syncytial virus infection.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}